Fig. 1From: Prospective comparison of early interim 18F-FDG-PET with 18F-FLT-PET for predicting treatment response and survival in metastatic breast cancerComparison of SUV and SUL changes between clinical responders and non-responders in patients with metastatic carcinoma. Clinical responders showed significant larger SUV and SUL changes on post-2c 18F-FDG-PET (P = 0.030 and 0.003) than non-respondersBack to article page